dawn pharmaceutical

Unverified company

Since 2023

Bangladesh

Our products

View all products

Osimertinib

Osinib is indicated for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation

lorlatinib

It is indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic Non-small Cell L

About Us

dawn was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.

Main Markets

Africa Asia North America South America

Africa
Asia
North America
South America

More about
dawn pharmaceutical

1000-5000

Employees

100K - 200K

Sales volume (USD)

30%

% Export sales

1974

Year

Established

Business type

Industry / Manufacturer
Distributor / Wholesaler

Keywords

medicine
drug

Contact and location

king lingkonglong
+880 xxxxxxxx
dhaka / uttora | Bangladesh

Make your Request!